Karyopharm Therapeutics Inc
NASDAQ:KPTI
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Karyopharm Therapeutics Inc
NASDAQ:KPTI
|
US |
|
L
|
Lockheed Martin Corp
BMV:LMT
|
US |
|
BYD Co Ltd
LSE:0VSO
|
CN |
|
Robinhood Markets Inc
F:7KY
|
US |
|
ALS Ltd
ASX:ALQ
|
AU |
|
P
|
PSI Software AG
XHAM:PSAN
|
DE |
|
G
|
Great Panther Mining Ltd
F:G3U
|
CA |
|
Healthcare Realty Trust Inc
NYSE:HR
|
US |
|
Z
|
Zoomcar Holdings Inc
NASDAQ:ZCAR
|
US |
|
E
|
East Japan Railway Co
F:EJR
|
JP |
|
A
|
Atlantica Sustainable Infrastructure PLC
F:AY3
|
UK |
|
M
|
MTU Aero Engines AG
XHAM:MTX
|
DE |
|
N
|
Novartis AG
SWB:NOT
|
CH |
|
Shenandoah Telecommunications Co
NASDAQ:SHEN
|
US |
|
L
|
L'Oreal SA
SWB:LOR
|
FR |
|
NeuPath Health Inc
XTSX:NPTH
|
CA |
|
M
|
Mitsui O.S.K. Lines Ltd
XBER:MILA
|
JP |
|
Telenor ASA
LSE:0G8C
|
NO |
|
K
|
Koninklijke Philips NV
SWB:PHI1
|
NL |
|
I
|
Investec Ltd
JSE:INL
|
ZA |
Wall St Price Targets
KPTI Price Targets Summary
Karyopharm Therapeutics Inc
According to Wall Street analysts, the average 1-year price target for KPTI is 13.67 USD with a low forecast of 7.07 USD and a high forecast of 16.8 USD.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is KPTI's stock price target?
Price Target
13.67
USD
According to Wall Street analysts, the average 1-year price target for KPTI is 13.67 USD with a low forecast of 7.07 USD and a high forecast of 16.8 USD.
What is the Revenue forecast for Karyopharm Therapeutics Inc?
Projected CAGR
24%
Over the last 13 years, the compound annual growth rate for Revenue has been 53%. The projected CAGR for the next 8 years is 24%.
What is the Gross Profit forecast for Karyopharm Therapeutics Inc?
Projected CAGR
15%
The compound annual growth rate for Gross Profit over the next 3 years is 15%.
